← Back to guidelines
Oncology3 papers

Oncocytic carcinoma of thyroid

Last edited: 4/10/2026

Overview

Oncocytic carcinoma of the thyroid is a type of thyroid carcinoma addressed by the NCCN Guidelines 1. The NCCN Thyroid Carcinoma Panel regularly reviews new data to update management recommendations for various thyroid carcinomas, including oncocytic carcinoma 1.

Diagnosis

  • Diagnosis is based on histopathological evaluation 1.
  • Further details on specific diagnostic criteria or grading are not provided in the abstracts.
  • Management

  • Management strategies for oncocytic carcinoma are addressed within the NCCN Guidelines for Thyroid Carcinoma 1.
  • The guidelines focus on systemic therapies for thyroid carcinoma, with updates based on new clinical data 1.
  • Specific treatment recommendations for oncocytic carcinoma are not detailed in the provided abstracts.
  • Special Populations

  • No information regarding special populations (pregnancy, pediatrics, elderly, comorbidities) is present in the abstracts.
  • Key Recommendations

  • The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of oncocytic carcinoma 1. (Evidence: Expert opinion)
  • The NCCN Thyroid Carcinoma Panel annually reviews new data to update recommendations for thyroid carcinoma management 1. (Evidence: Expert opinion)
  • NCCN Guidelines Insights focus on recent recommendations for systemic therapies for thyroid carcinoma 1. (Evidence: Expert opinion)
  • References

    1 Haddad RI, Bischoff L, Applewhite M, Bernet V, Blomain E, Brito M et al.. NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025. Journal of the National Comprehensive Cancer Network : JNCCN 2025. link

    Original source

    1. [1]
      NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025.Haddad RI, Bischoff L, Applewhite M, Bernet V, Blomain E, Brito M et al. Journal of the National Comprehensive Cancer Network : JNCCN (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG